The July 26 Wall Street Journal reported that the Food and Drug Administration is requiring new safety labels for Xeljanz. The warning applies to both Xeljanz and Xeljanz XR. The warning must advise patients that the 10-milligram twice daily...
Court Upholds $7.3 Mesothelioma Verdict
A Baltimore, Maryland jury determined in July 2019 that William Busch, Jr. developed mesothelioma due to asbestos exposure. It awarded the man $14 million, an amount which was reduced to $7.3 million. Busch performed non-insulation work for...
California Atripla Lawsuits To Be Combined Into One Court Action
A California judge has combined all Atripla lawsuits against Gilead Sciences, Inc., concerning its tenofovir disoproxil fumarate (TDF) medications. The lawsuits will be coordinated as a single action to allow efficient adjudication in the...